Long

ENDP - 26 year all time low

191
ENDO has 110B assets, 1.4B cash, 33B sales. In Q1 2022, revenue was 654M alone. It’s trading at a severely undervalued market cap of 141M.

This big pharma company also owns Plan B pill, one of two approved. POTUS has been tweeting about increasing supply to Plan B contraceptives.

ENDO just won an 8 year opioid lawsuit case Friday, July 1st.

Current DCF fair value is $6.59. Likely to be upgraded higher after debt restructuring and potential Plan B deals.

Their pipeline includes 50+ other OTC medications.

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.